3261 – HIGH RESOLUTION IDENTIFICATION OF LEUKEMIC CELL STATES USING A MULTIMODAL MANUAL CURATION FRAMEWORK

IF 2.7 4区 医学 Q2 HEMATOLOGY
Experimental hematology Pub Date : 2026-10-01 Epub Date: 2026-10-23 DOI:10.1016/j.exphem.2026.105583
Moritz Berg, Nesrine Aroua, Patrick Stelmach, Shuiping Lin, Maria Puschhof, Andreas Trumpp
{"title":"3261 – HIGH RESOLUTION IDENTIFICATION OF LEUKEMIC CELL STATES USING A MULTIMODAL MANUAL CURATION FRAMEWORK","authors":"Moritz Berg,&nbsp;Nesrine Aroua,&nbsp;Patrick Stelmach,&nbsp;Shuiping Lin,&nbsp;Maria Puschhof,&nbsp;Andreas Trumpp","doi":"10.1016/j.exphem.2026.105583","DOIUrl":null,"url":null,"abstract":"<div><div>Acute myeloid leukemia (AML) is a heterogeneous disease of the hematopoietic system characterized by the accumulation of dysfunctional stem and progenitor cells in the bone marrow. Relapse is driven by minimal residual disease, largely composed of leukemic stem cells (LSCs) that regenerate the leukemic hierarchy and confer chemotherapy resistance. Recently, tandem duplications (TD) of the upstream binding transcription factor (<em>UBTF</em>) gene have emerged as a common genomic alteration in pediatric AML and have also been identified in adults. The mechanisms driving UBTF-TD AML remain poorly understood and are further complicated by cellular heterogeneity, which shapes therapy resistance. High resolution characterization of UBTF-TD AML cell states is therefore required. We benchmarked Seurat and single-cell ANnotation using Variational Inference (scANVI)-based reference mapping in healthy hematopoiesis and AML as a performance baseline. Reference mapping reliably identified differentiated lineages but showed limited accuracy for progenitor populations, especially in AML. To address this, we designed a multimodal manual framework that integrates data-driven clustering, gene set enrichment, and profiling of surface markers. When applied to a cellular indexing of transcriptomes and epitopes by sequencing (CITE-seq) cohort of six patients with AML UBTF-TD (31,256 cells) spanning diagnosis and relapse, this framework enabled the resolution of leukemic progenitor cell states beyond the resolution achievable by reference mapping alone. Notably, an antigen-presenting hematopoietic stem cell population and a transcriptionally distinct pediatric AML-like subpopulation were characterized. Compositional analysis uncovered that AML UBTF-TD cellular composition is more primitive at relapse than at diagnosis, which is consistent with the known role of LSCs in disease recurrence. Compared with reference mapping based annotation, the manual curation recapitulated compositional patterns and cell states while providing additional biological resolution.</div></div><div>Acute myeloid leukemia (AML) is a heterogeneous disease of the hematopoietic system characterized by the accumulation of dysfunctional stem and progenitor cells in the bone marrow. Relapse is driven by minimal residual disease, largely composed of leukemic stem cells (LSCs) that regenerate the leukemic hierarchy and confer chemotherapy resistance. Recently, tandem duplications (TD) of the upstream binding transcription factor (<em>UBTF</em>) gene have emerged as a common genomic alteration in pediatric AML and have also been identified in adults. The mechanisms driving UBTF-TD AML remain poorly understood and are further complicated by cellular heterogeneity, which shapes therapy resistance. High resolution characterization of UBTF-TD AML cell states is therefore required. We benchmarked Seurat and single-cell ANnotation using Variational Inference (scANVI)-based reference mapping in healthy hematopoiesis and AML as a performance baseline. Reference mapping reliably identified differentiated lineages but showed limited accuracy for progenitor populations, especially in AML. To address this, we designed a multimodal manual framework that integrates data-driven clustering, gene set enrichment, and profiling of surface markers. When applied to a cellular indexing of transcriptomes and epitopes by sequencing (CITE-seq) cohort of six patients with AML UBTF-TD (31,256 cells) spanning diagnosis and relapse, this framework enabled the resolution of leukemic progenitor cell states beyond the resolution achievable by reference mapping alone. Notably, an antigen-presenting hematopoietic stem cell population and a transcriptionally distinct pediatric AML-like subpopulation were characterized. Compositional analysis uncovered that AML UBTF-TD cellular composition is more primitive at relapse than at diagnosis, which is consistent with the known role of LSCs in disease recurrence. Compared with reference mapping based annotation, the manual curation recapitulated compositional patterns and cell states while providing additional biological resolution.</div>","PeriodicalId":12202,"journal":{"name":"Experimental hematology","volume":"162 ","pages":"Article 105583"},"PeriodicalIF":2.7000,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Experimental hematology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0301472X2600216X","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/10/23 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Acute myeloid leukemia (AML) is a heterogeneous disease of the hematopoietic system characterized by the accumulation of dysfunctional stem and progenitor cells in the bone marrow. Relapse is driven by minimal residual disease, largely composed of leukemic stem cells (LSCs) that regenerate the leukemic hierarchy and confer chemotherapy resistance. Recently, tandem duplications (TD) of the upstream binding transcription factor (UBTF) gene have emerged as a common genomic alteration in pediatric AML and have also been identified in adults. The mechanisms driving UBTF-TD AML remain poorly understood and are further complicated by cellular heterogeneity, which shapes therapy resistance. High resolution characterization of UBTF-TD AML cell states is therefore required. We benchmarked Seurat and single-cell ANnotation using Variational Inference (scANVI)-based reference mapping in healthy hematopoiesis and AML as a performance baseline. Reference mapping reliably identified differentiated lineages but showed limited accuracy for progenitor populations, especially in AML. To address this, we designed a multimodal manual framework that integrates data-driven clustering, gene set enrichment, and profiling of surface markers. When applied to a cellular indexing of transcriptomes and epitopes by sequencing (CITE-seq) cohort of six patients with AML UBTF-TD (31,256 cells) spanning diagnosis and relapse, this framework enabled the resolution of leukemic progenitor cell states beyond the resolution achievable by reference mapping alone. Notably, an antigen-presenting hematopoietic stem cell population and a transcriptionally distinct pediatric AML-like subpopulation were characterized. Compositional analysis uncovered that AML UBTF-TD cellular composition is more primitive at relapse than at diagnosis, which is consistent with the known role of LSCs in disease recurrence. Compared with reference mapping based annotation, the manual curation recapitulated compositional patterns and cell states while providing additional biological resolution.
Acute myeloid leukemia (AML) is a heterogeneous disease of the hematopoietic system characterized by the accumulation of dysfunctional stem and progenitor cells in the bone marrow. Relapse is driven by minimal residual disease, largely composed of leukemic stem cells (LSCs) that regenerate the leukemic hierarchy and confer chemotherapy resistance. Recently, tandem duplications (TD) of the upstream binding transcription factor (UBTF) gene have emerged as a common genomic alteration in pediatric AML and have also been identified in adults. The mechanisms driving UBTF-TD AML remain poorly understood and are further complicated by cellular heterogeneity, which shapes therapy resistance. High resolution characterization of UBTF-TD AML cell states is therefore required. We benchmarked Seurat and single-cell ANnotation using Variational Inference (scANVI)-based reference mapping in healthy hematopoiesis and AML as a performance baseline. Reference mapping reliably identified differentiated lineages but showed limited accuracy for progenitor populations, especially in AML. To address this, we designed a multimodal manual framework that integrates data-driven clustering, gene set enrichment, and profiling of surface markers. When applied to a cellular indexing of transcriptomes and epitopes by sequencing (CITE-seq) cohort of six patients with AML UBTF-TD (31,256 cells) spanning diagnosis and relapse, this framework enabled the resolution of leukemic progenitor cell states beyond the resolution achievable by reference mapping alone. Notably, an antigen-presenting hematopoietic stem cell population and a transcriptionally distinct pediatric AML-like subpopulation were characterized. Compositional analysis uncovered that AML UBTF-TD cellular composition is more primitive at relapse than at diagnosis, which is consistent with the known role of LSCs in disease recurrence. Compared with reference mapping based annotation, the manual curation recapitulated compositional patterns and cell states while providing additional biological resolution.
3261 -高分辨率鉴定白血病细胞状态使用多模式手动策展框架
急性髓性白血病(AML)是一种造血系统的异质性疾病,其特征是骨髓中功能失调的干细胞和祖细胞的积累。复发是由微小残留疾病驱动的,主要由白血病干细胞(LSCs)组成,它们再生白血病层次并赋予化疗耐药性。最近,上游结合转录因子(UBTF)基因的串联重复(TD)已成为儿童AML中常见的基因组改变,也已在成人中发现。驱动UBTF-TD AML的机制仍然知之甚少,并且由于细胞异质性而进一步复杂化,这形成了治疗耐药性。因此,需要对UBTF-TD AML细胞状态进行高分辨率表征。我们在健康造血和AML中使用基于变分推理(scANVI)的参考映射对Seurat和单细胞ANnotation进行基准测试,作为性能基线。参考图谱可靠地确定了分化谱系,但对祖群体的准确性有限,特别是在AML中。为了解决这个问题,我们设计了一个多模式的手工框架,该框架集成了数据驱动的聚类、基因集富集和表面标记的分析。当应用于6名AML UBTF-TD患者(31,256个细胞)跨越诊断和复发的测序(CITE-seq)队列转录组和表位的细胞索引时,该框架使白血病祖细胞状态的分辨率超越了单独参考制图所能达到的分辨率。值得注意的是,抗原呈递的造血干细胞群和转录不同的儿科aml样亚群的特征。成分分析发现,AML UBTF-TD细胞成分在复发时比诊断时更原始,这与LSCs在疾病复发中的已知作用一致。与基于参考映射的注释相比,人工管理重现了成分模式和细胞状态,同时提供了额外的生物分辨率。急性髓性白血病(AML)是一种造血系统的异质性疾病,其特征是骨髓中功能失调的干细胞和祖细胞的积累。复发是由微小残留疾病驱动的,主要由白血病干细胞(LSCs)组成,它们再生白血病层次并赋予化疗耐药性。最近,上游结合转录因子(UBTF)基因的串联重复(TD)已成为儿童AML中常见的基因组改变,也已在成人中发现。驱动UBTF-TD AML的机制仍然知之甚少,并且由于细胞异质性而进一步复杂化,这形成了治疗耐药性。因此,需要对UBTF-TD AML细胞状态进行高分辨率表征。我们在健康造血和AML中使用基于变分推理(scANVI)的参考映射对Seurat和单细胞ANnotation进行基准测试,作为性能基线。参考图谱可靠地确定了分化谱系,但对祖群体的准确性有限,特别是在AML中。为了解决这个问题,我们设计了一个多模式的手工框架,该框架集成了数据驱动的聚类、基因集富集和表面标记的分析。当应用于6名AML UBTF-TD患者(31,256个细胞)跨越诊断和复发的测序(CITE-seq)队列转录组和表位的细胞索引时,该框架使白血病祖细胞状态的分辨率超越了单独参考制图所能达到的分辨率。值得注意的是,抗原呈递的造血干细胞群和转录不同的儿科aml样亚群的特征。成分分析发现,AML UBTF-TD细胞成分在复发时比诊断时更原始,这与LSCs在疾病复发中的已知作用一致。与基于参考映射的注释相比,人工管理重现了成分模式和细胞状态,同时提供了额外的生物分辨率。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Experimental hematology
Experimental hematology 医学-血液学
CiteScore
5.30
自引率
0.00%
发文量
84
审稿时长
58 days
期刊介绍: Experimental Hematology publishes new findings, methodologies, reviews and perspectives in all areas of hematology and immune cell formation on a monthly basis that may include Special Issues on particular topics of current interest. The overall goal is to report new insights into how normal blood cells are produced, how their production is normally regulated, mechanisms that contribute to hematological diseases and new approaches to their treatment. Specific topics may include relevant developmental and aging processes, stem cell biology, analyses of intrinsic and extrinsic regulatory mechanisms, in vitro behavior of primary cells, clonal tracking, molecular and omics analyses, metabolism, epigenetics, bioengineering approaches, studies in model organisms, novel clinical observations, transplantation biology and new therapeutic avenues.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书